Heritage Clarifies No Guilty Plea In US Settlement
Heritage has clarified that its recent settlement deal with the US Department of Justice over price-fixing allegations did not include the company entering a guilty plea.
You may also be interested in...
By the middle of next year, Emcure intends to have demerged its operations in highly developed markets from its activities in India and other emerging markets. The Indian group is seeking private-equity support to grow inorganically in North America and Europe.
Mylan, Sandoz and Teva, as well as Apotex, Aurobindo, Dr Reddy’s and Lupin, are among the companies accused of price-fixing in the US in an action brought by US insurance giant Humana.
Bernie Sanders and Elijah Cummings have written to the DoJ urging strict action against all generic drug manufacturing companies accused of a price-fixing conspiracy.